Clinical presentation
Ingestion of hallucinogenic drugs can cause hallucinations in all sensory modalities, as well as synaesthesia (the perception of one sense relating to another sense or part of the body [eg hearing a colour]).
Hallucinogenic drugs cause mental state and behavioural changes, and serotonergic toxidrome, which can be life threatening.
Novel psychedelic hallucinogenic drugs also have potent stimulant effects, and a higher risk of acute sympathomimetic toxidrome than established psychedelic hallucinogenic drugs.
See Drug examples and effects of hallucinogenic drugs for drug examples and effects of hallucinogenic drugs.
Dissociative hallucinogenic drugs | |
---|---|
drug examples |
ketamine (‘K’, ‘special K’) methoxetamine phencyclidine (PCP, ‘angel dust’) |
routes of use |
oral, inhalational (snorted, smoked), parenteral |
desired effects |
euphoria altered perception, synaesthesia [NB1] ‘out of body’ experience |
adverse effects |
aggression psychotic symptoms catatonia (‘K-hole’) acute reversible cerebellar toxicity |
Established psychedelic hallucinogenic drugs | |
drug examples |
partial serotonin agonists:
|
routes of use |
oral, sublingual (LSD) |
desired effects |
altered perception synaesthesia [NB1] hallucinations of all sensory modalities |
adverse effects |
behavioural disturbance psychotic symptoms physical injuries (sequelae of behavioural and psychotic effects) |
Novel psychedelic hallucinogenic drugs | |
drug examples |
2C–substituted phenylethylamines:
|
routes of use |
sublingual, inhalational (snorted, smoked), intravenous |
desired effects |
stimulation altered perception hallucinations |
adverse effects |
sympathomimetic toxidrome serotonergic toxidrome seizures behavioural disturbance psychotic symptoms sensation of paralysis rhabdomyolysis, kidney injury physical injuries (sequelae of other adverse effects) |
Note:
NB1: Synaesthesia is the perception of one sense relating to another sense or part of the body (eg hearing a colour). |